| |
|
|
|
Avadel Pharmaceuticals Plc  
|
|
6.75 0.28 (0.04%) |
05-25 16:00 |
|
Open: |
6.5 |
Pre close: |
6.47 |
Target:
|
8.05
|
|
High: |
6.84 |
Low: |
6.45 |
Resistance:
|
6.89
7.34
|
|
Volume: |
229,268 |
Market Cap: |
248M |
Support:
|
6.17
5.13
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.65
 |
MACD |
MACD(12,26):
|
-0.12  |
|
MA(20): |
6.75 |
Signal(12,26,9): |
-0.12 |
|
MA(100): |
8.09 |
Stochastic Oscillator |
%K(14,3):
|
21.86 |
|
MA(250): |
9.02 |
%D(3): |
28.03 |
|
Average Volume(K) |
3-Month: |
46060
|
52-Week |
High:
|
11.93 |
|
10-Days: |
44551 |
Low: |
6.17 |
|
RSI |
RSI(14):
|
46.18 |
Change(%): |
-30.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.340 |
Return on Equity (ttm) |
41.2 |
Shares Out. (M) |
36.75 |
|
EPS Est. Current Year |
1.160 |
Return on Assets (ttm) |
9.9 |
Shares Float (M) |
35.78 |
|
EPS Est. Next Year |
0.250 |
PEG Ratio |
-0.64 |
% Held by Insiders |
2.50 |
|
EPS Est. Next Quarter |
-0.100 |
Qtrly Rev. Growth |
-19.3 |
% Held by Institutions |
74.20 |
|
Forward EPS |
-0.060 |
Gross Profit (p.s.) |
2.113 |
Shares Short (K) |
3773 |
|
Book Value (p.s.) |
2.810 |
EBITDA (p.s.) |
1.689 |
P/E |
-19.85 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.40 |
|
Profit Margin |
19.62 |
Operating Cash Flow
(M) |
16.66 |
P/S |
57958528.00 |
|
Operating Margin |
35.21 |
Levered Free Cash Flow
(M) |
18.09 |
P/CF |
14.89 |
|
|
|
|
|
|
